Literature DB >> 15378250

[Cognitive impairment after accidental high-dose corticosteroid therapy].

M Arndt1, H J Kunert, H Sass, C Norra.   

Abstract

Synthetic glucocorticosteroids can induce various severe mental disorders. Persisting cognitive disorder represents a rare complication of corticoid therapy involving memory, concentration, attention, or occupational performance. We observed the effects of a 20-day self-induced high-dose corticosteroid treatment on the cognitive functions in a 54-year-old patient. Having excluded dementia due to other organic causes, we examined the patient neuropsychologically immediately at the end of the steroid therapy and at follow-up (1, 2, 4, and 6 months). The initial tests showed seriously impaired functioning of concentration, attention, learning, and memory as well as of common ability to solve problems. The follow-up tests up to 6 months revealed an improvement of concentration and attention, but there were still serious deficits of the declarative memory with a high confabulating tendency. Our results confirm those of human experimental studies that exogenous steroids can cause serious persisting specific cognitive disorders especially of the declarative, hippocampus-dependent memory.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15378250     DOI: 10.1007/s00115-003-1638-7

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  18 in total

Review 1.  Executive frontal functions.

Authors:  J M Fuster
Journal:  Exp Brain Res       Date:  2000-07       Impact factor: 1.972

2.  Improvement in learning associated with increase in hippocampal formation volume.

Authors:  Monica N Starkman; Bruno Giordani; Stephen S Gebarski; David E Schteingart
Journal:  Biol Psychiatry       Date:  2003-02-01       Impact factor: 13.382

3.  Cortisol reduces hippocampal glucose metabolism in normal elderly, but not in Alzheimer's disease.

Authors:  M J de Leon; T McRae; H Rusinek; A Convit; S De Santi; C Tarshish; J Golomb; N Volkow; K Daisley; N Orentreich; B McEwen
Journal:  J Clin Endocrinol Metab       Date:  1997-10       Impact factor: 5.958

4.  Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons.

Authors:  C S Woolley; E Gould; B S McEwen
Journal:  Brain Res       Date:  1990-10-29       Impact factor: 3.252

5.  Persistent cognitive impairment following surgical treatment of Cushing's syndrome.

Authors:  Hélène Forget; André Lacroix; Henri Cohen
Journal:  Psychoneuroendocrinology       Date:  2002-04       Impact factor: 4.905

6.  Stress- and treatment-induced elevations of cortisol levels associated with impaired declarative memory in healthy adults.

Authors:  C Kirschbaum; O T Wolf; M May; W Wippich; D H Hellhammer
Journal:  Life Sci       Date:  1996       Impact factor: 5.037

7.  Glucocorticoids and cognitive function: from physiology to pathophysiology.

Authors:  Karen Jameison; Timothy G. Dinan
Journal:  Hum Psychopharmacol       Date:  2001-06       Impact factor: 1.672

8.  Decreased memory performance in healthy humans induced by stress-level cortisol treatment.

Authors:  J W Newcomer; G Selke; A K Melson; T Hershey; S Craft; K Richards; A L Alderson
Journal:  Arch Gen Psychiatry       Date:  1999-06

Review 9.  The brain as a target for adrenocortical steroids: cognitive implications.

Authors:  E Martignoni; A Costa; E Sinforiani; A Liuzzi; P Chiodini; M Mauri; G Bono; G Nappi
Journal:  Psychoneuroendocrinology       Date:  1992-08       Impact factor: 4.905

10.  [Cortisone-induced psychoses].

Authors:  P Bräunig; J Bleistein
Journal:  Nervenarzt       Date:  1988-10       Impact factor: 1.214

View more
  3 in total

Review 1.  [Effects of high-dose cortisone therapy on cognition].

Authors:  I Uttner; H Tumani
Journal:  Nervenarzt       Date:  2006-06       Impact factor: 1.214

Review 2.  Glucocorticosteroids in football: use and misuse.

Authors:  J Dvorak; N Feddermann; K Grimm
Journal:  Br J Sports Med       Date:  2006-07       Impact factor: 13.800

Review 3.  Influences on cognition by immunosuppression and immunomodulation in multiple sclerosis.

Authors:  Hayrettin Tumani; Ingo Uttner
Journal:  J Neurol       Date:  2007-05       Impact factor: 4.849

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.